Pierre Ecclestone
Corporate Officer/Principal at VALEO PHARMA INC.
Net worth: - $ as of 2024-04-29
Profile
Pierre Ecclestone is currently the Vice President of Business Development at Valeo Pharma, Inc. since 2023.
Prior to this, he held the same position at Aralez Pharmaceuticals Canada, Inc. from 2021 to 2023.
Before that, he worked as a Principal at Pce Pharma Consulting, Inc. from 2017 to 2021.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
-.--% | 2023-09-12 | 0 ( -.--% ) | - $ | 2024-04-29 |
Pierre Ecclestone active positions
| Companies | Position | Start |
|---|---|---|
| VALEO PHARMA INC. | Corporate Officer/Principal | 2023-07-31 |
Former positions of Pierre Ecclestone
| Companies | Position | End |
|---|---|---|
| TRIBUTE PHARMACEUTICALS CANADA INC | Corporate Officer/Principal | 2023-03-31 |
| Pce Pharma Consulting, Inc. | Corporate Officer/Principal | 2020-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VALEO PHARMA INC. | Health Technology |
| Private companies | 2 |
|---|---|
Aralez Pharmaceuticals Canada, Inc.
 Aralez Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Canada, Inc. operates as a pharmaceutical company which focuses on the acquisition, licensing, development, and promotion of healthcare products. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The company was founded by Peter Roy Riehl and Robert Paul Harris on November 14, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
| Pce Pharma Consulting, Inc. |
- Stock Market
- Insiders
- Pierre Ecclestone
